Results 201 to 210 of about 7,402 (232)

The long-term effectiveness and mechanism of oncolytic virotherapy combined with anti-PD-L1 antibody in colorectal cancer patient. [PDF]

Cancer Gene Ther
Zhang H, Ren Y, Wang F, Tu X, Tong Z, Liu L, Zheng Y, Zhao P, Cheng J, Li J, Fang W, Liu X.   +11 more
europepmc   +1 more source

Identification of restrictive molecules involved in oncolytic virotherapy using genome-wide CRISPR screening. [PDF]

J Hematol Oncol
Zhong Y, Le H, Zhang X, Dai Y, Guo F, Ran X, Hu G, Xie Q, Wang D, Cai Y.   +9 more
europepmc   +1 more source

IL-12-mediated toxicity from localized oncolytic virotherapy can be reduced using systemic TNF blockade. [PDF]

Mol Ther Oncol
Valenzuela-Cardenas M, Fisher C, Bartee MY, Bartee E.   +3 more
europepmc   +1 more source

Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy. [PDF]

Viruses
Calderón-Peláez MA, Maradei Anaya SJ, Bedoya-Rodríguez IJ, González-Ipuz KG, Vera-Palacios D, Buitrago IV, Castellanos JE, Velandia-Romero ML.   +7 more
europepmc   +1 more source

Development of a robust cell-based potency assay for a coxsackievirus A21 oncolytic virotherapy. [PDF]

Heliyon
Chamcha V, He L, Jenny Xu, Swartz AR, Green-Trexler E, Gurney K, McNeely T.   +6 more
europepmc   +1 more source

Oncolytic virotherapy stimulates anti‑tumor immune response and demonstrates activity in advanced sarcoma: Report of two cases. [PDF]

Oncol Lett
Qiu Y, Qin A, Zhao R, Ding J, Jia WW, Singh M, Murad Y, Tan Q, Kichenadasse G.   +8 more
europepmc   +1 more source

Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy. [PDF]

Front Immunol
Zarezadeh Mehrabadi A, Tat M, Ghorbani Alvanegh A, Roozbahani F, Esmaeili Gouvarchin Ghaleh H.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Oncolytic Virotherapy

2023
Oncolytic virotherapy opens up avenues for cancer treatment by selectively targeting the cancer cells and destructs them either through direct lysis or by inducing an immune response in the tumor microenvironment. This platform technology utilizes a diverse range naturally existing or genetically modified oncolytic viruses for their immunotherapeutic ...
Munazza, Fatima, Deeba, Amraiz, Muhammad Tariq, Navid   +2 more
openaire   +2 more sources